Position in AMGN
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$675,353
-$366,123 QoQ
Shares Held
1,865
-37.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.45%
of 13F equity value
Holder Rank
#1,978
of 3,139 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Elevated Capital Advisors, LLC holds $4,373,518 across 13 Drug Manufacturers - General names. AMGN ranks #3 (15.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
4,263 | $1,082,674 | |
| 2 | ABBV |
AbbVie Inc.
|
3,945 | $992,719 | |
| 3 | AMGN |
Amgen Inc
This page
|
1,865 | $675,353 | |
| 4 | PFE |
Pfizer Inc
|
21,185 | $510,134 | |
| 5 | LLY |
ELI LILLY & Co
|
382 | $458,182 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
5,669 | $326,647 | |
| 7 | MRK |
Merck & Co., Inc.
|
2,351 | $302,103 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
97 | $12,254 |
All Filings in AMGN
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $675,353 | 1,865 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $1,041,476 | 2,960 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $392,444 | 1,199 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $397,055 | 1,407 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $438,638 | 1,571 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $489,445 | 1,571 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $433,704 | 1,664 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $495,881 | 1,539 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $468,987 | 1,501 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $377,576 | 1,328 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $354,264 | 1,230 | Shares | Sole | 2024-01-09 | |
| 2023-09-30 | $299,936 | 1,116 | Shares | Sole | 2023-10-17 | |
| 2023-06-30 | $252,214 | 1,136 | Shares | Sole | 2023-08-18 | |
| 2023-03-31 | $242,233 | 1,002 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $248,457 | 946 | Shares | Sole | 2023-01-17 | |
| No filing history on record for this holder in this stock. | ||||||